<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FDA Approval on FinanClub</title>
    <link>https://finan.club/tags/fda-approval/</link>
    <description>Recent content in FDA Approval on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 18 Aug 2023 11:04:36 +0000</lastBuildDate><atom:link href="https://finan.club/tags/fda-approval/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BSX</title>
      <link>https://finan.club/us/bsx/</link>
      <pubDate>Fri, 18 Aug 2023 11:04:36 +0000</pubDate>
      
      <guid>https://finan.club/us/bsx/</guid>
      <description>score:34
Chances: Boston Scientific&amp;rsquo;s POLARx technology offers doctors the flexibility to tailor ablation treatments to individual patient anatomies, potentially enhancing treatment effectiveness. The FDA approval of the POLARx Cryoablation System for paroxysmal atrial fibrillation indicates the company&amp;rsquo;s commitment to advancing medical technology and addressing medical needs.</description>
    </item>
    
  </channel>
</rss>
